Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

Table 4 Comparison between the demographics of the NIFG and that of the IFG before and after matching

	NIFG	IFG	Standardized difference
Before matching
Number of people	273	604
Sex women, %	72.9	76.7	0.084
Age years, mean ± SD	87.1 ± 7.2	85.7 ± 8.2	0.18
EQ-5D-5L scores mean ± SD	0.63 ± 0.26	0.63 ± 0.25	0.012
BI scores mean ± SD	59.3 ± 33.7	63.2 ± 32.2	0.12
MMSE scores mean ± SD	16.0 ± 9.5	17.4 ± 8.4	0.15
DBD scores mean ± SD	17.6 ± 14.1	15.6 ± 13.6	0.14
VI scores mean ± SD	7.4 ± 2.7	7.50 ± 2.6	0.038
Medication costs JPY/day, mean ± SD	429.8 ± 504.8	542.1 ± 706.1	0.18
Number of medications mean ± SD	7.0 ± 3.5	7.10 ± 3.7	0.041
After matching
Number of people	234	459
Sex women, %	72.2	75.6	0.075
Age years, mean ± SD	86.7 ± 7.3	87.0 ± 7.0	0.037
EQ-5D-5L scores mean ± SD	0.64 ± 0.27	0.64 ± 0.25	0.0010
BI scores mean ± SD	61.2 ± 34.0	61.3 ± 32.4	0.0040
MMSE scores mean ± SD	16.7 ± 9.5	16.5 ± 8.3	0.012
DBD scores mean ± SD	16.2 ± 13.3	16.3 ± 14.0	0.0083
VI scores mean ± SD	7.4 ± 2.7	7.5 ± 2.6	0.020
Medication costs JPY/day, mean ± SD	451.1 ± 534.2	457.0 ± 515.2	0.011
Number of medications mean ± SD	7.0 ± 3.5	6.8 ± 3.7	0.045

NIFG (not implemented facilities group), participants who were not in facilities where proposals for improving inappropriate prescriptions were implemented by the end of March 2020 were classified into this group
IFG (implemented facilities group), participants who were in facilities where proposals for improving inappropriate prescriptions were implemented by the end of March 2020 were classified into this group

ISSN: 1471-2318